[1. HENTER JI., HORNE A., ARICÓ M., EGELER RM., FILIPOVICH AH., IMASHUKU S., et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocyticlymphohistiocytosis. Pediatr Blood Cancer. 2007; 48(2):124-31.10.1002/pbc.21039]Open DOISearch in Google Scholar
[2. TAN EM., COHEN AS., FRIES JF., MASI AT., MCSHANE DJ., ROTHFIELD NF., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-7.10.1002/art.1780251101]Search in Google Scholar
[3. BODE SF., LEHMBERG K., MAUL-PAVICIC A., VRAETZ T., JANKA G., STADT UZ., et al. Recent advances in the diagnosis and treatment of hemophagocyticlymphohistiocytosis. Arthritis Res Ther. 2012; 14(3):213.10.1186/ar3843]Open DOISearch in Google Scholar
[4. FUKAYA S., YASUDA S., HASHIMOTO T., OKU K., KATAOKA H., HORITA T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008; 47(11):1686-91.10.1093/rheumatology/ken342]Search in Google Scholar
[5. EGÜES DUBUC CA., URIARTE ECENARRO M., MENESES VILLALBA C., ALDASORO CÁCERES V., HERNANDO RUBIO I., BELZUNEGUI OTANO J. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus. Reumatol Clin. 2014; 10(5):321-4.10.1016/j.reumae.2013.09.004]Search in Google Scholar
[6. KUMAKURA S., MURAKAWA Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol. 2014; 66(8):2297-307.10.1002/art.38672]Search in Google Scholar
[7. JORDAN MB., ALLEN CE., WEITZMAN S., FILIPOVICH AH., MCCLAIN KL. How I treat hemophagocyticlym-phohistiocytosis. Blood. 2011; 118(15):4041-52.10.1182/blood-2011-03-278127]Open DOISearch in Google Scholar
[8. HANNAH J., CASIAN A., D’CRUZ D. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. Autoimmun Rev. 2016; 15(1):93-101.10.1016/j.autrev.2015.09.006]Search in Google Scholar